ABSTRACT
Objective Arthritis is a chronic condition affecting hundreds of millions of people worldwide, often leading to pain and functional limitations. This study aimed to investigate the direct and indirect effects of pain on functional independence in individuals with arthritis. Depressive symptoms and physical activity were examined as potential mediators of this relationship.
Methods A total of 6972 participants with arthritis (4930 with osteoarthritis and 694 with rheumatoid arthritis) were included from the Canadian Longitudinal Study on Aging. Multiple linear regression models, generalized linear models, and bootstrapping were used to assess the relationships between baseline pain, depressive symptoms, physical activity, and functional status at follow-up.
Results Baseline pain was positively associated with depressive symptoms (b = 0.356 [95% CI: 0.310 to 0.402]) and negatively associated with physical activity (b = −0.083 [95% CI: −0.125 to −0.042]). Functional status at follow-up was significantly predicted by baseline pain (OR = 1.834 [95% CI: 1.306 to 2.610]), depressive symptoms (OR = 1.431 [95% CI: 1.205 to 1.709]), and physical activity (OR = 0.550 [95% CI: 0.440 to 0.683]). Mediation analysis showed that 30.4% of the effect of pain on functional status was mediated by the total indirect effect, with contributions from depressive symptoms (19.8%), physical activity (8.9%), and the serial mediation pathway (1.7%).
Conclusions Pain at baseline was associated with a higher likelihood of functional dependence in basic and instrumental activities of daily living after a mean follow-up period of 6.3 years, with depressive symptoms and lower physical activity acting as partial mediators. These findings highlight the importance of managing pain, mental health, and physical activity in patients with arthritis to maintain functional independence.
Impact These findings support the importance for intervention to target both mental health and exercise to mitigate functional decline resulting from the long-term effects of pain in patients with arthritis.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding for CLSA is provided by the Government of Canada through the Canadian Institutes of Health Research (CIHR) (LSA 94473), the Canada Foundation for Innovation (CFI), and the following Canadian provinces: Alberta, British Columbia, Manitoba, Newfoundland, Nova Scotia, Ontario, Quebec. Matthieu P. Boisgontier is supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) (RGPIN-2021-03153) and the CFI. Zachary M. van Allen is supported by a Mitacs Accelerate Postdoctoral Fellowship and the Banting Discovery Foundation. Martin Bilodeau is supported by NSERC (RGPIN-2018-06526).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the University of Ottawa Research Ethics Board (H-10-23-9760).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The R scripts used to analyse the data are publicly available in Zenodo: https://doi.org/10.5281/zenodo.14847424. This research was made possible using the data collected by the Canadian Longitudinal Study on Aging (CLSA) and was conducted using the CLSA Baseline Comprehensive Dataset version 7.0, Follow-Up 1 Comprehensive Dataset version 5.0, and Follow-Up 2 Comprehensive dataset version 2.0 under application number 2304015. This dataset is available for researchers who meet the criteria (www.clsa-elcv.ca).
